Search

Your search keyword '"Periard, Daniel"' showing total 22 results
Start Over Author "Periard, Daniel"
22 results on '"Periard, Daniel"'

2. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study

Author

Zeller, Thomas, Torsello, Giovanni, Tepe, Gunnar, Peeters, Patrick, Scheinert, Dierk, Bosiers, Marc, Maene, Lieven, Micari, Antonio, Do, Dai-Do, Hendriks, Jeroen, Keirse, Koen, Brodmann, Marianne, Merkely, Bela, Lardenoije, Jan-Willem, Ruzsa, Zoltan, Vogel, Britta, Veroux, Pierfrancesco, Albuquerque e Castro, Joao, Periard, Daniel, Ludyga, Tomasz, Midy, Dominique, Choi, Donghoon, Lansink, Wouter, Ketelsen, Dominik, Dubenec, Steven, Banyai, Martin, Chakfe, Nabil, Roithinger, Franz Xaver, Trani, Carlo, Mansour, Hossam, Rha, Seung-Woon, Vermassen, Frank, Belenky, Alexander, Spak, Lubomir, Chalmers, Nicholas, Benko, Andrew, Kum, Steven, Won, Je Hwan, Vozar, Matej, Tan, Kong Teng, Labib, Mamdouh, de Borst, Gert-Jan, Do, Young-Soo, Teijink, Joep, Gomez, Juan Fernando, Falkowski, Aleksander, Ferreira, Luis, Matela, Jozef, Lee, Seung-Whan, Verhoeven, Bart, Mannheim, Dalit, Nessi, Franco, Vulev, Ivan, de Vries, Jean-Paul, Maly, Radovan, Kavteladze, Zaza, Turner, Douglas, Mendiz, Oscar, Kolvenbach, Ralf, Karnabatidis, Dimitrios, Cuellar, Cesar, Venermo, Maarit, Velicka, Linas, Lundberg, Goran, Frost, Martin, and Wang, Hong

Published
2018
Full Text
View/download PDF

4. Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis

Author

Suh, Young Joo, primary, Hong, Hyunsook, additional, Ohana, Mickaël, additional, Bompard, Florian, additional, Revel, Marie-Pierre, additional, Valle, Clarissa, additional, Gervaise, Alban, additional, Poissy, Julien, additional, Susen, Sophie, additional, Hékimian, Guillaume, additional, Artifoni, Mathieu, additional, Periard, Daniel, additional, Contou, Damien, additional, Delaloye, Julie, additional, Sanchez, Bienvenido, additional, Fang, Cheng, additional, Garzillo, Giorgio, additional, Robbie, Hasti, additional, and Yoon, Soon Ho, additional

Published
2021
Full Text
View/download PDF

5. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort

Author

Torsello, Giovanni, primary, Stavroulakis, Konstantinos, additional, Brodmann, Marianne, additional, Micari, Antonio, additional, Tepe, Gunnar, additional, Veroux, Pierfrancesco, additional, Benko, Andrew, additional, Choi, Donghoon, additional, Vermassen, Frank E. G., additional, Jaff, Michael R., additional, Guo, Jia, additional, Dobranszki, Reka, additional, Zeller, Thomas, additional, Torsello, Giovanni, additional, Peeters, Patrick, additional, Scheinert, Dierk, additional, Bosiers, Marc, additional, Maene, Lieven, additional, Do, Dai-Do, additional, Hendriks, Jeroen, additional, Keirse, Koen, additional, Merkely, Bela, additional, Lardenoije, Jan-Willem, additional, Ruzsa, Zoltan, additional, Vogel, Britta, additional, Albuquerque e Castro, Joao, additional, Periard, Daniel, additional, Ludyga, Tomasz, additional, Midy, Dominique, additional, Lansink, Wouter, additional, Ketelsen, Dominik, additional, Dubenec, Steven, additional, Banyai, Martin, additional, Chakfe, Nabil, additional, Xaver Roithinger, Franz, additional, Trani, Carlo, additional, Mansour, Hossam, additional, Rha, Seung-Woon, additional, Vermassen, Frank, additional, Belenky, Alexander, additional, Spak, Lubomir, additional, Chalmers, Nicholas, additional, Kum, Steven, additional, Won, Je Hwan, additional, Vozar, Matej, additional, Teng Tan, Kong, additional, Labib, Mamdouh, additional, Borst, Gert-Jan de, additional, Do, Young-Soo, additional, Teijink, Joep, additional, Gomez, Juan Fernando, additional, Falkowski, Aleksander, additional, Ferreira, Luis, additional, Matela, Jozef, additional, Lee, Seung-Whan, additional, Verhoeven, Bart, additional, Mannheim, Dalit, additional, Nessi, Franco, additional, Vulev, Ivan, additional, Vries, Jean-Paul de, additional, Maly, Radovan, additional, Kavteladze, Zaza, additional, Turner, Douglas, additional, Mendiz, Oscar, additional, Kolvenbach, Ralf, additional, Karnabatidis, Dimitrios, additional, Cuellar, Cesar, additional, Venermo, Maarit, additional, Velicka, Linas, additional, and Lundberg, Goran, additional

Published
2020
Full Text
View/download PDF

9. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain

Author

Micari, Antonio, primary, Brodmann, Marianne, additional, Keirse, Koen, additional, Peeters, Patrick, additional, Tepe, Gunnar, additional, Frost, Martin, additional, Wang, Hong, additional, Zeller, Thomas, additional, Torsello, Giovanni, additional, Scheinert, Dierk, additional, Bosiers, Marc, additional, Maene, Lieven, additional, Micari, Antonio, additional, Do, Dai-Do, additional, Hendriks, Jeroen, additional, Merkely, Bela, additional, Lardenoije, Jan-Willem, additional, Ruzsa, Zoltan, additional, Vogel, Britta, additional, Veroux, Pierfrancesco, additional, Albuquerque e Castro, Joao, additional, Periard, Daniel, additional, Ludyga, Tomasz, additional, Midy, Dominique, additional, Choi, Donghoon, additional, Lansink, Wouter, additional, Ketelsen, Dominik, additional, Dubenec, Steven, additional, Banyai, Martin, additional, Chakfe, Nabil, additional, Roithinger, Franz Xaver, additional, Trani, Carlo, additional, Mansour, Hossam, additional, Rha, Seung-Woon, additional, Vermassen, Frank, additional, Belenky, Alexander, additional, Spak, Lubomir, additional, Chalmers, Nicholas, additional, Benko, Andrew, additional, Kum, Steven, additional, Won, Je Hwan, additional, Vozar, Matej, additional, Tan, Kong Teng, additional, Labib, Mamdouh, additional, de Borst, Gert-Jan, additional, Do, Young-Soo, additional, Teijink, Joep, additional, Gomez, Juan Fernando, additional, Falkowski, Aleksander, additional, Ferreira, Luis, additional, Matela, Jozef, additional, Lee, Seung-Whan, additional, Verhoeven, Bart, additional, Mannheim, Dalit, additional, Nessi, Franco, additional, Vulev, Ivan, additional, de Vries, Jean-Paul, additional, Maly, Radovan, additional, Kavteladze, Zaza, additional, Turner, Douglas, additional, Mendiz, Oscar, additional, Kolvenbach, Ralf, additional, Karnabatidis, Dimitrios, additional, Cuellar, Cesar, additional, Venermo, Maarit, additional, Velicka, Linas, additional, and Lundberg, Goran, additional

Published
2018
Full Text
View/download PDF

10. High Prevalence of Peripheral Arterial Disease in HIV-Infected Persons

Author

Periard, Daniel, Cavassini, Matthias, Taffé, Patrick, Chevalley, Melanie, Senn, Laurence, Chapuis-Taillard, Caroline, de Vallière, Serge, Hayoz, Daniel, Tarr, Philip E., Periard, Daniel, Cavassini, Matthias, Taffé, Patrick, Chevalley, Melanie, Senn, Laurence, Chapuis-Taillard, Caroline, de Vallière, Serge, Hayoz, Daniel, and Tarr, Philip E.

Abstract

Background. Atherosclerosis has been assessed in human immunodeficiency virus (HIV)-infected persons by using various methods. Peripheral arterial disease (PAD) has not been evaluated, however. We studied the cross-sectional prevalence of lower limb PAD in an HIV-infected population. Methods. PAD was assessed using the Edinburgh Claudication Questionnaire and by measuring the systolic ankle-brachial blood pressure index (ABI) at rest and after exercise. Patients with PAD were further evaluated by duplex scan of lower limb arteries. Results. Ninety-two consecutive HIV-infected patients were evaluated (23.9% women; mean age, 49.5 years; 61.9% current smokers). Claudication was reported by 15.2% of the patients. PAD was found in 20.7% of the patients: 9.8% had an abnormal ABI (<0.90) at rest, and 10.9% had normal ABI at rest but a >25% decrease after exercise. Of the patients with PAD, 84.2% were investigated with duplex scan, all of whom had atherosclerotic occlusions or stenoses of the iliac or femoral arteries. Age, diabetes, smoking, and low CD4+ T lymphocyte counts were identified as independent predictors of PAD. Conclusions. The prevalence of symptomatic and asymptomatic PAD is high in the HIV-infected population and is much higher than expected (prevalence in the general population, ∼3% at 60 years). This study suggests the presence of an epidemic of PAD ∼20 years earlier in the HIV-infected than in the general population. Larger epidemiological studies are needed to better define risk factors and to evaluate whether PAD is associated with increased mortality, as it is in the general population

Published
2017

12. Changes in Aortic Pulse Wave Velocity in Hypertensive Postmenopausal Women: Comparison Between a Calcium Channel Blocker vs Angiotensin Receptor Blocker Regimen

Author

Hayoz, Daniel, Zappe, Dion H., Meyer, Marie A.R., Baek, InYoung, Kandra, Albert, Joly, Marie P., Mazzolai, Lucia, Haesler, Erik, and Periard, Daniel

Subjects
Male, Tetrazoles, Blood Pressure, Valine, Middle Aged, Pulse Wave Analysis, Calcium Channel Blockers, Original Papers, Postmenopause, Vascular Stiffness, Double-Blind Method, Hypertension, Humans, Valsartan, Female, Amlodipine, Angiotensin II Type 1 Receptor Blockers, Aged
Abstract

J Clin Hypertens (Greenwich). 2012;14:773–778. ©2012 Wiley Periodicals, Inc. Postmenopausal women are at greater risk for hypertension‐related cardiovascular disease. Antihypertensive therapy may help alleviate arterial stiffness that represents a potential modifiable risk factor of hypertension. This randomized controlled study investigated the difference between an angiotensin receptor blocker and a calcium channel blocker in reducing arterial stiffness. Overall, 125 postmenopausal hypertensive women (age, 61.4±6 years; systolic blood pressure/diastolic blood pressure [SBP/DBP], 158±11/92±9 mm Hg) were randomized to valsartan 320 mg±hydrochlorothiazide (HCTZ) (n=63) or amlodipine 10 mg±HCTZ (n=62). The primary outcome was carotid‐to‐femoral pulse wave velocity (PWV) changes after 38 weeks of treatment. Both treatments lowered peripheral blood pressure (BP) (−22.9/−10.9 mm Hg for valsartan and −25.2/−11.7 mm Hg for amlodipine, P=not significant) and central BP (−15.7/−7.6 mm Hg for valsartan and −19.2/−10.3 mm Hg for amlodipine, P

Published
2012

20. High Prevalence of Peripheral Arterial Disease in HIV-Infected Persons

Author

Periard, Daniel, Cavassini, Matthias, Taffé, Patrick, Chevalley, Melanie, Senn, Laurence, Chapuis-Taillard, Caroline, de Vallière, Serge, Hayoz, Daniel, Tarr, Philip E., Periard, Daniel, Cavassini, Matthias, Taffé, Patrick, Chevalley, Melanie, Senn, Laurence, Chapuis-Taillard, Caroline, de Vallière, Serge, Hayoz, Daniel, and Tarr, Philip E.

Abstract

Background. Atherosclerosis has been assessed in human immunodeficiency virus (HIV)-infected persons by using various methods. Peripheral arterial disease (PAD) has not been evaluated, however. We studied the cross-sectional prevalence of lower limb PAD in an HIV-infected population. Methods. PAD was assessed using the Edinburgh Claudication Questionnaire and by measuring the systolic ankle-brachial blood pressure index (ABI) at rest and after exercise. Patients with PAD were further evaluated by duplex scan of lower limb arteries. Results. Ninety-two consecutive HIV-infected patients were evaluated (23.9% women; mean age, 49.5 years; 61.9% current smokers). Claudication was reported by 15.2% of the patients. PAD was found in 20.7% of the patients: 9.8% had an abnormal ABI (<0.90) at rest, and 10.9% had normal ABI at rest but a >25% decrease after exercise. Of the patients with PAD, 84.2% were investigated with duplex scan, all of whom had atherosclerotic occlusions or stenoses of the iliac or femoral arteries. Age, diabetes, smoking, and low CD4+ T lymphocyte counts were identified as independent predictors of PAD. Conclusions. The prevalence of symptomatic and asymptomatic PAD is high in the HIV-infected population and is much higher than expected (prevalence in the general population, ∼3% at 60 years). This study suggests the presence of an epidemic of PAD ∼20 years earlier in the HIV-infected than in the general population. Larger epidemiological studies are needed to better define risk factors and to evaluate whether PAD is associated with increased mortality, as it is in the general population

22. Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins.

Author

Periard D, Guessous I, Mazzolai L, Haesler E, Monney P, and Hayoz D

Subjects
Aged, Aorta, Abdominal diagnostic imaging, Aortic Aneurysm, Abdominal diagnosis, Aortography methods, Chi-Square Distribution, Disease Progression, Female, Humans, Linear Models, Male, Middle Aged, Multivariate Analysis, Retrospective Studies, Risk Assessment, Risk Factors, Switzerland, Time Factors, Tomography, X-Ray Computed, Treatment Outcome, Ultrasonography, Aorta, Abdominal drug effects, Aortic Aneurysm, Abdominal drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors
Abstract

Background: To evaluate the effect of statins on the annual expansion rate (ER) of small infrarenal abdominal aortic aneurysms (AAA)., Patients and Methods: All patients under regular surveillance for small AAA between January 2000 and September 2007, in the Department of Angiology, Lausanne University Hospital, were included. Inclusion criteria were baseline abdominal aortic diameter between 25 and 55 mm, at least two measurements of AAA diameter and a minimum follow up of 6 months. Patients with Marfan disease, infectious or inflammatory AAA, and patients with prior AAA repair were excluded. The influence of statin use and other factors on ER were examined by bivariate and multivariate analysis., Results: Among 589 patients who underwent an abdominal aorta evaluation, 94 patients (89 % men, mean age 69.1 years) were finally included in the analysis. Baseline AAA size was 39.9 ± 7.7 mm (mean±SE) and 48.7 ± 8.4 mm at end of follow-up. Patients had a regular aneurysm size assessment during 38.5 ± 27.7 months. Mean ER was 3.59 mm/y (± 2.81). The 50 patients who were treated with statin during the study period had a lower ER compared to the 44 controls (2.91 vs 4.37 mm/year, p = 0.01)., Conclusions: This study confirms the considerable individual variations in the AAA expansion rate, and emphasizes the need for regular aortic diameter assessments. In this study, patients treated with statin demonstrate a significant decrease in the ER compared to controls. This finding need to be evaluated in prospective interventional studies powered to demonstrate the potential benefit of statin treatment.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results